Tuesday, March 2, 2021

COVID-19 vaccine | Hyderabad-based Biological E may help Johnson Johnson fulfil global orders: Report

COVID-19 vaccine | Hyderabad-based Biological E may help Johnson Johnson fulfil global orders: Report Biological E has a target of manufacturing of roughly 600 million doses of Janssen annually.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/covid-19-vaccine-|-hyderabad-based-biological-e-may-help-johnsonjohnson-fulfil-global-orders-report_14900101.html
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...